E09.321
Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code E09.321 refers to a form of diabetes mellitus caused by drug or chemical exposure. This condition is characterized by mild nonproliferative diabetic retinopathy accompanied by macular edema. The disease affects blood sugar regulation and can impact vision due to eye complications associated with diabetes.
Causes & Symptoms
Clinical Causes: Use of certain medications or chemicals known to affect insulin production or sensitivity Long-term exposure to toxic substances that impair pancreatic function Medical treatments or therapies that have side effects leading to elevated blood glucose levels Pre-existing health conditions exacerbated by medication use
Key Symptoms: Blurred or distorted vision Dark spots or floaters in the field of vision Mild swelling or thickening of the macula, leading to visual impairment Signs of elevated blood sugar, such as increased thirst and frequent urination Possible subtle changes in vision that develop gradually
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, blood tests to measure sugar levels, and eye examinations. Fundus photography and optical coherence tomography (OCT) are used to detect and assess diabetic retinopathy and macular edema. The healthcare provider may also review medication history to identify potential drug-induced causes.
Treatment Protocols: Management strategies focus on controlling blood sugar levels and addressing eye health. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is E09.321 a billable ICD-10 code?
Yes, E09.321 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.321?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
